Finance Expert Career Guidance
Get unlimited access to premium research & analysis
Tissium raises €60M to take its sutureless nerve glue to the US
1 min read

Tissium raises €60M to take its sutureless nerve glue to the US

Tissium has raised €60M to carry the world’s only FDA-cleared sutureless nerve repair system into US operating rooms. The Paris medtech wants to swap the surgeon’s needle for a dab…

Executive Summary

Real-time Market Intelligence

Tissium has raised €60M to carry the world’s only FDA-cleared sutureless nerve repair system into US operating rooms.

Tissium has raised €60M to carry the world’s only FDA-cleared sutureless nerve repair system into US operating rooms. The Paris medtech wants to swap the surgeon’s needle for a dab of light-cured glue. For a severed nerve, the standard repair has barely changed in decades. A surgeon stitches the two frayed ends together under a […] This story continues at The Next Web

Tissium raises €60M to take its sutureless ne...

This $60m transaction represents significant deal activity. Market participants including The Paris are actively engaged.

Updated Jun 25, 2026

Deal Value Comparison

Chart Analysis
  • YTD High leads with 84.0 m, the highest value across all 4 categories analyzed.
  • YTD Low trails at the lowest position with 21.0 m, a 75% gap from the leader.
  • The average across all categories is 52.5 m.
  • 2 out of 4 categories perform above average.

Strategic Drivers

Chart Analysis
  • Market Position dominates with 35.0% market share, representing the largest segment in this distribution.
  • The second largest segment is Growth Potential at 28.0%, trailing by 7.0 percentage points.
  • The remaining 2 segments collectively represent 37.0% of the total.

Premium Analysis

Subscribe to unlock full market intelligence

Ask Senna Ask about this article... AI